Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-21

Clinical Trial Update: Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee [Phase 3]

View source ↗

Summary

A Phase 3 trial of Buprenorphine Transdermal System for moderate-to-severe knee osteoarthritis chronic pain has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPRENORPHINE TRANSDERMAL SYSTEM (buprenorphine)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Chronic Pain, Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED | Results posted: 2010-09-21